GSKMEX:GSKN 73 FCF Yield % is 6.07 as of Jun. 24, 2026, which is 25% below its 10-year median of 8.11. GuruFocus rates MEX:GSKN with a GF Score™ of 73/100 and a GF Value™ of MXN818.82 (Fairly Valued). The stock has 1 warning sign investors should review. Among 1,005 Drug Manufacturers companies, GSK ranks better than 77.41% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, GSK's Trailing 12-Month Free Cash Flow is MXN118,143 Mil, and Market Cap is MXN1,805,212 Mil. Therefore, GSK's FCF Yield % for today is 6.07%.
The historical rank and industry rank for GSK's FCF Yield % or its related term are showing as below:
MEX:GSKN'
s FCF Yield % Range Over the Past 10 Years
Min: 2.27 Med: 8.11 Max: 13.51
Current: 6.07
During the past 13 years, the highest FCF Yield % of GSK was 13.51%. The lowest was 2.27%. And the median was 8.11%.
MEX:GSKN's FCF Yield % is ranked better than 77.41% of 1005
companies
in the Drug Manufacturers industry
Industry Median: 0.69
vs MEX:GSKN: 6.07
GSK's FCF Margin % for the quarter that ended in Mar. 2026 was 9.15%.
GSK FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
GSK FCF Yield % Related Terms
GSK FCF Yield % Historical Data
* Premium members only.
The historical data trend for GSK's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:GSKN vs LLY, JNJ, ABBV: FCF Yield % Comparison
For the Drug Manufacturers - General subindustry, GSK's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GSK FCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, GSK's FCF Yield % distribution charts can be found below:
* The bar in red indicates where GSK's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GSK (MEX:GSKN) has a FCF Yield % of 6.07 as of Jun. 24, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on GSK and its competitors. This is 25% below median its historical median of 8.11. Over the past decade, GSK's FCF Yield % has ranged from 2.27 to 13.51. According to the industry distribution chart, GSK ranks #227 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 22.6%.
Is GSK's FCF Yield % too high?
GSK's current FCF Yield % of 6.07 is 25% below median its 10-year median of 8.11. Over the past 10 years, this metric has ranged from a low of 2.27 to a high of 13.51. The Drug Manufacturers industry median FCF Yield % is 0.69. GSK's value of 6.07 is 779.7% above this industry median. Based on the distribution chart, GSK ranks #227 out of 1005 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, GSK has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does GSK's FCF Yield % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, GSK ranks #227 out of 1005 companies for FCF Yield %. This places GSK in the top 23% of its industry — outperforming the majority of peers. The industry median FCF Yield % is 0.69. GSK's value of 6.07 is 779.7% above this benchmark. Historically, GSK's own FCF Yield % has ranged from 2.27 to 13.51 over the past decade. While the company's 10-year median is 8.11 vs. the industry median of 0.69, GSK has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Drug Manufacturers company?
The median FCF Yield % among Drug Manufacturers companies is 0.69, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GSK's current FCF Yield % of 6.07 is 779.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on GSK and its competitors. For the Drug Manufacturers industry, the median FCF Yield % is 0.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GSK's current FCF Yield % is 6.07, which is 25% below median its own 10-year median of 8.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GSK stock overvalued right now?
Based on GuruFocus' analysis, GSK (MEX:GSKN) is currently considered Fairly Valued. The stock's GF Value™ is MXN818.82, compared to a current price of MXN901.11 — trading 10% above its estimated fair value. The current FCF Yield % is 6.07, which is 25% below median its 10-year median of 8.11 and 779.7% above the Drug Manufacturers industry median of 0.69. GSK's overall GF Score™ is 73/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For GSK (MEX:GSKN), the current FCF Yield % is 6.07 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GSK (MEX:GSKN) Overvalued in 2026?
Based on GuruFocus' analysis, GSK stock appears to be overvalued.
The current stock price of MXN901.11 is trading 10% above its estimated GF Value™ of MXN818.82.
GuruFocus considers GSK to be Fairly Valued.
Key valuation signals for MEX:GSKN:
FCF Yield %: 6.07 (25% below median its 10-year median of 8.11)
GF Value™: MXN818.82 vs. price of MXN901.11 (10% above fair value)
Industry Position: 779.7% above the Drug Manufacturers median (#227 of 1005)
No single metric tells the full story. See the MEX:GSKN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
73GF Score
Get the complete analysis for MEX:GSKN
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:GSKN has been successfully added to your 
